| CGQGX | DYGAX | CGQGX / DYGAX | |
| Total Expense Ratio | 0.63 | 1.09 | 58% |
| Annual Report Gross Expense Ratio | 0.68 | 1.09 | 62% |
| Fund Existence | 7 years | 9 years | - |
| Gain YTD | 21.756 | 11.836 | 184% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 24.9B | 482M | 5,166% |
| Annual Yield % from dividends | 0.43 | 1.27 | 34% |
| Returns for 1 year | 12.78 | 9.64 | 133% |
| Returns for 3 years | 61.95 | 36.87 | 168% |
| Returns for 5 years | 37.45 | 19.47 | 192% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBE | 84.16 | 1.03 | +1.24% |
| Invesco Biotechnology & Genome ETF | |||
| OPTZ | 36.81 | 0.20 | +0.55% |
| Optimize Strategy Index ETF | |||
| ARP | 32.79 | N/A | N/A |
| PMV Adaptive Risk Parity ETF | |||
| RDTL | 48.69 | -0.06 | -0.12% |
| GraniteShares 2x Long RDDT Daily ETF | |||
| ULTY | 38.82 | -0.49 | -1.25% |
| YieldMax Ultra Option Income Strat ETF | |||